ライフサイエンスコーパス: leukocyte adhesion

1 by integrin-dependent sickle-red blood cell-leukocyte adhesion.

2 m by which LA1-activated CD11b/CD18 mediates leukocyte adhesion.

3 and is critical for firm integrin-dependent leukocyte adhesion.

4 t captures CTCs while minimizing nonspecific leukocyte adhesion.

5 LFA-1 also mediates leukocyte adhesion.

6 of mobility for the onset of LFA-1 mediated leukocyte adhesion.

7 the inhibition of exocytosis, and suppresses leukocyte adhesion.

8 othelium (P = 0.03) matching the increase in leukocyte adhesion.

9 lammatory signals with those associated with leukocyte adhesion.

10 microglial activation, and reduced cerebral leukocyte adhesion.

11 ed ICAM-1 in endothelial cells (EC) promotes leukocyte adhesion.

12 ation into plaques through platelet-mediated leukocyte adhesion.

13 s an important regulator of CX3CL1-dependent leukocyte adhesion.

14 a preceding activation step to trigger firm leukocyte adhesion.

15 for antithrombotic therapy based on blocking leukocyte adhesion.

16 on and digestion to regulating bacterial and leukocyte adhesion.

17 lar adhesion molecule-1 dependent intestinal leukocyte adhesion.

18 finity triggering mediates chemokine-induced leukocyte adhesion.

19 tion of HC-HA cable structures and abolishes leukocyte adhesion.

20 ry factor, which inhibits integrin-dependent leukocyte adhesion.

21 the markers of thrombosis, inflammation, and leukocyte adhesion.

22 onal change in beta2 integrins, facilitating leukocyte adhesion.

23 APN-KO mice also exhibited increased leukocyte adhesion (2.3+/-0.4-fold) and tumor necrosis f

24 e (CX3CL1) and its receptor, CX3CR1, mediate leukocyte adhesion, activation, and trafficking.

25 ional biology: a mechanics-based modeling of leukocyte adhesion (adhesive dynamics) and signal transd

26 and partly prevented increases in VCAM-1 and leukocyte adhesion after treatment with tumour necrosis

27 creased permeability, ICAM-1 expression, and leukocyte adhesion, all of which are features of an infl

28 ated a crucial role for CatG during arterial leukocyte adhesion, an effect not found during venular a

29 uorescence microscopy, we observed excessive leukocyte adhesion and accelerated atherosclerotic plaqu

30 nflammation, vascular lesions with increased leukocyte adhesion and capillary degeneration.

31 In contrast, polymorphonuclear leukocyte adhesion and chemotaxis were normal.

32 gulates many biological processes, including leukocyte adhesion and chemotaxis.

33 clerosis in ApoE(-/-) mice, there is reduced leukocyte adhesion and decreased CD18 expression on Gr1(

34 9)/L platelets, showing reduced signaling in leukocyte adhesion and diapedesis and increased compleme

35 DPA and RvD5n-3 DPA decreased the extent of leukocyte adhesion and emigration following ischemia-rep

36 ntified role for Panx1 channels in promoting leukocyte adhesion and emigration through the venous wal

37 ade body secretion, and in the regulation of leukocyte adhesion and extravasation during inflammation

38 ion in the genetic absence of Coro1A impairs leukocyte adhesion and extravasation in inflamed cremast

39 muscle venules revealed severely compromised leukocyte adhesion and extravasation in MK(-/-) mice com

40 control endothelial cell (EC) permeability, leukocyte adhesion and inflammation are pivotal for athe

41 JAM-C thereby mediated both leukocyte adhesion and leukocyte transendothelial migrat

42 show that N-glycosylation of JAM-A regulates leukocyte adhesion and LFA-1 binding.

43 ligands and their ability to intervene with leukocyte adhesion and migration across brain endothelia

44 CX3CR1 is a chemokine receptor involved in leukocyte adhesion and migration and hence a mediator of

45 egment of the microvasculature that supports leukocyte adhesion and migration expands through remodel

46 Constitutive leukocyte adhesion and migration in murine bone marrow (

47 l antibody against alpha4 integrin, inhibits leukocyte adhesion and migration into inflamed tissue.

48 The finding that Cdk inhibitors can block leukocyte adhesion and migration may expand the clinical

49 t human fetal HSCs employ mechanisms used in leukocyte adhesion and migration to mediate HSC self-ren

50 nd its ligand CX3CL1 have been implicated in leukocyte adhesion and neuronal protection.

51 ultiple integrin-induced events important in leukocyte adhesion and phagocytosis.

52 dothelial activation manifested as increased leukocyte adhesion and plasma extravasation in response

53 ta2-integrin activation is indispensable for leukocyte adhesion and recruitment to sites of infection

54 L-selectin regulates leukocyte adhesion and rolling along the endothelium.

55 new role of fibrinogen in integrin-mediated leukocyte adhesion and suggest that this mechanism may p

56 tify alpha 4 integrin/CD49d as a mediator of leukocyte adhesion and the resultant early signature abn

57 protein I (beta2GPI) induce endothelial cell-leukocyte adhesion and thrombus formation via unknown me

58 ould be used as a therapeutic tool to reduce leukocyte adhesion and thus reduce neuroinflammation.

59 or investigation of lymphatic involvement in leukocyte adhesion and trafficking during the immune res

60 the effects of hemodynamics and cytokines on leukocyte adhesion and trans-endothelial migration (TEM)

61 t human JAM-C to determine its role in human leukocyte adhesion and transendothelial cell migration u

62 ion of endothelial ABPs to the regulation of leukocyte adhesion and transendothelial migration remain

63 e their endothelial cell ligands and support leukocyte adhesion and transendothelial migration.

64 Consequently, leukocyte adhesion and transmigration are significantly

65 l in vivo, elastic laminae were resistant to leukocyte adhesion and transmigration compared with the

66 synthase and fibrinolytic activity, decrease leukocyte adhesion and transmigration, and enhance resis

67 functions including macrophage recognition, leukocyte adhesion and transmigration.

68 beta while an anti-ICAM-1 mAb inhibited both leukocyte adhesion and transmigration.

69 F-induced proliferation and thrombin-induced leukocyte adhesion and triggers a STAT3-dependent increa

70 dase is positively correlated with increased leukocyte adhesion and vascular leakage in diabetes and

71 s and reduced significantly diabetes-induced leukocyte adhesion and vascular leakage.

72 and smooth muscle cell apoptosis as well as leukocytes adhesion and proliferation.

73 is, cell growth and apoptosis, angiogenesis, leukocyte adhesion, and cytokine activation and inhibiti

74 hamber protein concentration, retinal vessel leukocyte adhesion, and protein leakage were measured 24

75 at plays a role in tight junction formation, leukocyte adhesion, and transendothelial migration.

76 cells is essential for platelet aggregation, leukocyte adhesion, and transmigration through endotheli

77 a-AR stimulation can promote both SS RBC and leukocyte adhesion as well as vaso-occlusion, suggesting

78 AnxA1Ac2-26 treatment decreased leukocyte adhesion at 40 min and all L-E interactions at

79 sing IVM, we could detect instant changes in leukocyte adhesion behavior in the synovial vessels of t

80 ies in the murine inflamed microcirculation (leukocyte adhesion being the readout) and in skin traffi

81 , the retinas were extracted and assayed for leukocyte adhesion; blood-retinal barrier breakdown; VEG

82 hoG by small interfering RNA does not affect leukocyte adhesion but decreases cup formation and inhib

83 tyrosine phosphatase 1 (Shp1) show increased leukocyte adhesion, but the interpretation of these data

84 of the immunoglobulin superfamily, supports leukocyte adhesion by binding alpha4beta1 integrins and

85 3 cells, suggesting that these miRs regulate leukocyte adhesion by modulating the expression of adhes

86 Understanding of the leukocyte adhesion cascade and interactions of leukocyte

87 Despite expanded definition of the leukocyte adhesion cascade and mechanisms underlying ind

88 These data provide unique insights in the leukocyte adhesion cascade and the potential for time-ba

89 Current in vitro models of the leukocyte adhesion cascade cannot be used for real-time

90 The leukocyte adhesion cascade is important in chronic lymph

91 tion in vivo and add additional steps to the leukocyte adhesion cascade that supports leukocyte traff

92 be used for real-time studies of the entire leukocyte adhesion cascade, including rolling, adhesion,

93 N-glycans contributing to all aspects of the leukocyte adhesion cascade, O-glycans only being importa

94 sses have been identified in the endothelial-leukocyte adhesion cascade.

95 llular MRP8/14 as an autocrine player in the leukocyte adhesion cascade.

96 In view of the capacity of FKN to mediate leukocyte adhesion, chemoattraction, and transmigration,

97 neally) resulted in a three-fold increase in leukocyte adhesion, compared with ischemia/reperfusion a

98 This diminished leukocyte adhesion correlated with the magnitude of gran

99 Leukocyte adhesion, crawling, and transmigration are reg

100 s in this disappearance, a dog having canine leukocyte adhesion deficiency (CLAD) or CLAD dogs who ha

101 Canine leukocyte adhesion deficiency (CLAD) represents the cani

102 e use of foamy virus vectors to treat canine leukocyte adhesion deficiency (CLAD).

103 umans, mutations in beta(2) integrin lead to leukocyte adhesion deficiency (LAD) syndrome and mutatio

104 activation on neutrophils is the hallmark of leukocyte adhesion deficiency (LAD) syndrome in humans,

105 PURPOSE OF REVIEW: The leukocyte adhesion deficiency (LAD) syndromes are rare g

106 the canine counter-part of the human disease leukocyte adhesion deficiency (LAD).

107 in inherited and acquired disorders, such as leukocyte adhesion deficiency and myelodysplasia.

108 Chronic granulomatous disease and leukocyte adhesion deficiency are the major primary immu

109 autosomal recessive disease characterized by leukocyte adhesion deficiency as well as severe neurolog

110 ontrasts with the phenotype seen in type III leukocyte adhesion deficiency caused by the absence of k

111 nd identify CF as a new, cell type-selective leukocyte adhesion deficiency disease, providing new ins

112 The protein kindlin 3 is mutated in the leukocyte adhesion deficiency III (LAD-III) disorder, le

113 In the disorder leukocyte adhesion deficiency III (LAD-III), integrins o

114 e severe than those reported for people with leukocyte adhesion deficiency III (LAD-III).

115 de an effective, but less toxic approach for leukocyte adhesion deficiency in children.

116 SCs, and thus lack of CD18 expression in the leukocyte adhesion deficiency patients may predispose th

117 ivation on leukocytes is the hallmark of the leukocyte adhesion deficiency syndrome in humans, charac

118 f young dogs with the genetic disease canine leukocyte adhesion deficiency that were treated with a n

119 A patient with leukocyte adhesion deficiency type 1 (LAD1) had severe p

120 e the contribution of CD18 on neutrophils to leukocyte adhesion deficiency type I (LAD-I), a complex

121 se), severe congenital neutropenia (SCN) and leukocyte adhesion deficiency type I confer a predisposi

122 LADII (leukocyte adhesion deficiency type II)/CDGIIc (congenita

123 hypofucosylated in PMNs from a patient with leukocyte adhesion deficiency type II, suggesting that i

124 lts imply that the immunodeficiency found in leukocyte adhesion deficiency type III patients, in addi

125 accumulation of HSPCs in the circulation of leukocyte adhesion deficiency type III patients, who lac

126 hat is mutated in the rare genetic disorder, leukocyte adhesion deficiency type III, a disorder chara

127 n-3 is mutated in the rare genetic disorder, leukocyte adhesion deficiency type III, which is charact

128 Leukocyte adhesion deficiency type-1 (LAD-1) is an autos

129 enital origin (e.g., congenital neutropenia, leukocyte adhesion deficiency, and Chediak-Higashi syndr

130 cell activity is impaired, but not absent in leukocyte adhesion deficiency, may lead to the developme

131 which die perinatally of severe bleeding and leukocyte adhesion deficiency, mice expressing as little

132 Subjects with leukocyte adhesion deficiency-1 (LAD-I) do not express b

133 A canine model of leukocyte adhesion deficiency-I facilitated development

134 Preimplantation genetic diagnosis of leukocyte adhesion deficiency-I led to the birth of a no

135 adhesion deficiency-I; prenatal diagnosis of leukocyte adhesion deficiency-I; and association of auto

136 e adhesion deficiency-I; transplantation for leukocyte adhesion deficiency-I; prenatal diagnosis of l

137 herapy for chronic granulomatous disease and leukocyte adhesion deficiency-I; transplantation for leu

138 been advances in understanding the basis of leukocyte adhesion deficiency-II and III.

139 ng kindlin-3, the protein that is mutated in leukocyte adhesion deficiency-III patients.

140 Patients with Glanzmann thrombasthenia or Leukocyte Adhesion Deficiency-III syndrome (LAD-III or L

141 tudying a patient with kindlin-3 deficiency (leukocyte adhesion deficiency-III).

142 nderlie the human immune deficiency known as leukocyte adhesion deficiency-III.

143 ll transplant and gene therapy approaches to leukocyte adhesion deficiency.

144 E) abolished the inhibitory effect of gAd on leukocyte adhesion, demonstrating the obligatory role of

145 Leukocyte adhesion during inflammation is initiated by t

146 electin, ICAM-1, and EphB4 and were sites of leukocyte adhesion during lipopolysaccharide-induced acu

147 Superfusion with IS induced strong leukocyte adhesion, enhanced extravasation, and interrup

148 lence at least in part by impeding Fg-driven leukocyte adhesion events.

149 When MDMECs were evaluated for leukocyte adhesion, exposure to CLP serum caused increas

150 Similarly, leukocyte adhesion, extravasation, and bacterial clearan

151 of temporal patterns of rhodamine-6G-labeled leukocyte adhesion/extravasation, was used.

152 molecules, including interleukin (IL)-6, the leukocyte adhesion factor ICAM1, and chemokines that att

153 ter B lymphocytes from mice with a defect in leukocyte adhesion fail to divide asymmetrically.

154 explain the shear threshold effect, in which leukocyte adhesion goes through a maximum with increasin

155 ctionally important endogenous inhibitors of leukocyte adhesion have not been identified.

156 Intravitreal IL-6 directly induced leukocyte adhesion in both wild-type and IL-6-deficient

157 muscle confirmed the defect of CXCL1-induced leukocyte adhesion in HPK1-deficient mice.

158 rolling on unstimulated veins and increased leukocyte adhesion in inflamed veins.

159 ate the complex roles this integrin plays in leukocyte adhesion in inflammation.

160 ceded clinical signs of anterior uveitis and leukocyte adhesion in iris vasculature.

161 eceptors in endothelial cells also increased leukocyte adhesion in mesenteric venules and increased t

162 tin ligands act as competitive inhibitors of leukocyte adhesion in models of inflammation.

163 rteriogenesis, thrombosis, inflammation, and leukocyte adhesion in patients with intermittent claudic

164 rupts capillary fine structure and increases leukocyte adhesion in postcapillary venules.

165 Insulin decreased VCAM-1 expression and leukocyte adhesion in quiescent tumour endothelial cells

166 1INH significantly inhibit selectin-mediated leukocyte adhesion in several in vitro and in vivo model

167 This article discusses the importance of leukocyte adhesion in sickle cell disease, and how this

168 ]-3-methyl-cyclohexanol), greatly attenuated leukocyte adhesion in surface pial vessels and in deep a

169 n leukocyte rolling and a 5-fold increase in leukocyte adhesion in the microcirculation.

170 nd cytokine response with a marked degree of leukocyte adhesion in the microcirculation.

171 Leukocyte adhesion in the microvasculature influences bl

172 d protein content in the aqueous fluid, firm leukocyte adhesion in the retinal vessels, and the numbe

173 d the mechanistic roles of hyperglycemia and leukocyte adhesion in this process.

174 l Del-1 deficiency increased LFA-1-dependent leukocyte adhesion in vitro and in vivo.

175 ion molecules (ICAMs) in cis, which inhibits leukocyte adhesion in vitro and in vivo.

176 Using a leukocyte adhesion in vitro assay under shear forces mim

177 pproximately 33 mumol) mitigated LPS-induced leukocyte adhesion in WT and AnxA1-null animals without

178 h soluble fibrinogen exerts its influence on leukocyte adhesion indicated that it did not block integ

179 studied endothelial permeability, intravital leukocyte adhesion, involvement of the Akt/WNT/beta-cate

180 Integrin-mediated leukocyte adhesion is central to this process.

181 Leukocyte adhesion is determined by the balance between

182 Leukocyte adhesion is mediated mainly by selectins, cell

183 organization of endothelial ICAM-1 regulates leukocyte adhesion is not well understood.

184 Leukocyte adhesion is regulated through the modulation o

185 A key parameter influencing leukocyte adhesion is the shear stress acting on the leu

186 Leukocyte adhesion is triggered by the interaction of va

187 platelet dysfunction in addition to impaired leukocyte adhesion, is now known to be due to absence of

188 m from obese mice expressed higher levels of leukocyte adhesion markers and lower levels of cell-cell

189 ignificantly increased the expression of the leukocyte adhesion markers LFA-1 and VLA-4, consistent w

190 Platelet-leukocyte adhesion may contribute to thrombosis and infl

191 Evidence suggests that disrupting leukocyte adhesion may prevent the impairment of renal m

192 macrophage-1 antigen complex, which mediates leukocyte adhesion, migration and phagocytosis as part o

193 and functions in diverse capacities such as leukocyte adhesion, migration, and cell survival on liga

194 dose of natalizumab, an antibody against the leukocyte adhesion molecule alpha4 integrin, in patients

195 this report, we have determined that the EC-leukocyte adhesion molecule E-selectin is a key target f

196 E-selectin, a leukocyte adhesion molecule expressed on endothelium, is

197 irectly suppressed endothelial activation of leukocyte adhesion molecule expression and inflammation.

198 or the synthesis of functional selectin-type leukocyte adhesion molecule ligands.

199 ical surface, where JAM-A played a role as a leukocyte adhesion molecule participating in transendoth

200 E-selectin, an inducible leukocyte adhesion molecule specifically expressed by en

201 Increased leukocyte adhesion molecule VCAM-1 expression and leukoc

202 observed elevated expression of endothelial leukocyte adhesion molecule-1, a human glaucoma marker,

203 but under inflammatory conditions acts as a leukocyte adhesion molecule.

204 ulatory role in cytokine induction of the EC-leukocyte adhesion molecules (ELAM) E-selectin and vascu

205 Therefore, the expression of leukocyte adhesion molecules and secretion of proinflamm

206 eta2 integrins (CD11/CD18) are heterodimeric leukocyte adhesion molecules expressed on hematopoietic

207 A recent study shows that the leukocyte adhesion molecules known as selectins form 'ca

208 TNF-alpha induces leukocyte adhesion molecules on endothelial cells (ECs),

209 t, Rho GTPases affect the expression of some leukocyte adhesion molecules on endothelial cells, such

210 In contrast, the genes for leukocyte adhesion molecules showed a significant upregu

211 esion, and extravasation by up-regulation of leukocyte adhesion molecules such as E-selectin and P-se

212 e-inducible, NF-kappaB-dependent endothelial-leukocyte adhesion molecules that participate in the leu

213 tigated the role of p75 in TNF-alpha-induced leukocyte adhesion molecules using cultured ECs derived

214 elial cells, their expression of ligands for leukocyte adhesion molecules, and vaso-occlusion.

215 ir ability to regulate the expression of key leukocyte adhesion molecules, on both leukocytes and end

216 capillaries enlarged into venules expressing leukocyte adhesion molecules, sprouting angiogenesis and

217 that the phenolic content of RW may modulate leukocyte adhesion molecules, whereas both ethanol and p

218 T cells (Tn) are expanded in mice that lack leukocyte adhesion molecules, which have neutrophilia an

219 associated with endothelial upregulation of leukocyte adhesion molecules, which persist even after i

220 Transient mild leukocyte adhesion occurred in mCMV-ND venules at 7 and

221 or IL-6, and their retinas were analyzed for leukocyte adhesion or for the expression and localizatio

222 a(2+)]i in endothelial cells does not affect leukocyte adhesion or locomotion but selectively blocks

223 strains lacking Pra1p were unable to support leukocyte adhesion or migration.

224 No significant leukocyte adhesion or rolling, nor changes in capillary

225 ndogenous inhibitors, as well as the role of leukocyte adhesion-promoting molecules) has provided new

226 Mechanisms controlling leukocyte adhesion, propulsion and directional migration

227 matory markers, neutrophil chemoattractants, leukocyte adhesion proteins, and matrix metalloproteases

228 coli strains, targets a broad range of human leukocyte adhesion proteins.

229 form to the TNFalpha-induced upregulation of leukocyte adhesion proteins.

230 We report that in addition to supporting leukocyte adhesion, provision of specific substrate to V

231 shear stress responses, and TNFalpha-induced leukocyte adhesion rates characteristic of arterial endo

232 y increases in endothelial expression of the leukocyte adhesion receptor E-selectin and in microvascu

233 xide production, and by direct modulation of leukocyte adhesion receptor expression.

234 CD44, the leukocyte adhesion receptor for hyaluronan, has been con

235 The leukocyte adhesion receptor L-selectin forms bonds with

236 Pases are activated by engagement of several leukocyte adhesion receptors and contribute to both earl

237 lls (LECs), leading to expression of the key leukocyte adhesion receptors intercellular adhesion mole

238 The selectin family of leukocyte adhesion receptors is principally recognized f

239 G, interact with ICAM-1 and are recruited to leukocyte adhesion sites.

240 tivity C-reactive protein, osteopontin), and leukocyte adhesion (soluble vascular cell adhesion molec

241 addressed this problem, two key features of leukocyte adhesion, such as cell deformation and rolling

242 n endothelial cells and, in turn, to augment leukocyte adhesion, thus exacerbating S1P-mediated proad

243 chronic inflammatory disease associated with leukocyte adhesion to and extravasation through vascular

244 Leukocyte adhesion to brain endothelial cells, the blood

245 a inhibition in vivo substantially decreased leukocyte adhesion to brain endothelium under inflammato

246 PolyI:C-induced, HA-mediated leukocyte adhesion to colon SMCs from STAT1-null mice wa

247 Leukocyte adhesion to endothelium and platelets plays an

248 treated SS RBCs induced activation of murine leukocyte adhesion to endothelium as well.

249 ich SS RBCs act via LW and CD44 to stimulate leukocyte adhesion to endothelium, and suggest that RBC

250 so purified LFA-1, an integrin that mediates leukocyte adhesion to endothelium.

251 expression in renal vascular endothelium and leukocyte adhesion to endothelium.

252 is study investigated the regulation of firm leukocyte adhesion to human brain endothelium by two dif

253 igation rapidly activated integrin-dependent leukocyte adhesion to immobilized ICAM-1 and fibronectin

254 in multiple leukocyte populations, impaired leukocyte adhesion to inflamed vessels, and accumulation

255 Leukocyte adhesion to P-selectin on activated platelets

256 ation of AnxA1(2-50) markedly reduced (>60%) leukocyte adhesion to postcapillary venules in wild type

257 e blockade of NAD(P)H oxidase in turn blocks leukocyte adhesion to retinal vessels during diabetes an

258 tent with these findings, we found increased leukocyte adhesion to sdc-1 knock-out endothelial cells

259 rst description of a mechanism that prevents leukocyte adhesion to the endothelium by a parasite and

260 Furthermore, IL-35 inhibited leukocyte adhesion to the endothelium in the vessels of

261 However, leukocyte adhesion to the fibrin clot can be detrimental

262 It promotes leukocyte adhesion to the liver in vivo and drives lymph

263 dose-dependently inhibited TNF-alpha-induced leukocyte adhesion to the murine cremasteric arterioles

264 ed increases in IL-6 mRNA and protein and in leukocyte adhesion to the retinal vessels.

265 ET-1-treated PbN-infected mice displayed leukocyte adhesion to the vascular endothelia and petech

266 ology of diabetic retinopathy is mediated by leukocyte adhesion to the vascular endothelium of the di

267 Inhibition of leukocyte adhesion to the vascular endothelium represent

268 Leukocyte adhesion to the vascular wall is a critical ea

269 Intriguingly, leukocyte adhesion to the vasculature is significantly i

270 t limits endothelial activation and prevents leukocyte adhesion to the vessel wall.

271 dition of heavy chains to HA cables enhanced leukocyte adhesion to these cables, but it also had seve

272 Finally, HDL inhibited leukocyte adhesion to TNFalpha-stimulated ECs isolated f

273 to nude mice promotes both SS RBC and murine leukocyte adhesion to vascular endothelium in vivo.

274 s (such as VCAM-1 the ligand for VLA-4), and leukocyte adhesion to vascular endothelium.

275 been implicated in the multistep process of leukocyte adhesion to vascular endothelium.

276 Human polymorphonuclear leukocytes adhesion to endothelial cells during the earl

277 nd hemorrhagic shock did not further amplify leukocytes adhesion to intestinal venules compared with

278 oxemia and hemorrhagic shock did not amplify leukocytes adhesion to the endothelium further than eith

279 Furthermore, hemorrhagic shock triggered leukocytes adhesion to the venular endothelium to the sa

280 Hypoxemia also triggered leukocytes adhesion to the venular endothelium.

281 y for rapid activation of integrin-dependent leukocyte adhesion, triggered by toll-like receptor (TLR

282 the essential role for TXNIP in mediating EC-leukocyte adhesion under d-flow, as well as define a nov

283 c IgG and assembled immune complexes amplify leukocyte adhesion under dynamic conditions.

284 core-1/Galbeta1,3GalNAc glycan may regulate leukocyte adhesion under fluid shear.

285 llular adhesion molecule-1 (ICAM-1) mediates leukocyte adhesion under force.

286 ppressed the LPS-induced increase in retinal leukocyte adhesion; vascular leakage; NF-kappaB, HIF-1al

287 r contributed to activation of NF-kappaB and leukocyte adhesion via the EC induction of intercellular

288 glycosylation, sialyl Lewis-X formation, and leukocyte adhesion via the selectins.

289 Leukocyte adhesion was assayed by concanavalin A labelin

290 Leukocyte adhesion was assessed by labeling adherent leu

291 Platelet and leukocyte adhesion was assessed in cortical venules with

292 Platelet and leukocyte adhesion was elevated and blood/brain barrier

293 Leukocyte adhesion was evaluated by chemotaxis and in vi

294 ferase FUT9 played an important role because leukocyte adhesion was reduced by 50-60% in FUT9-HL-60,

295 tically upregulated at the onset of hypoxia, leukocyte adhesion was unaffected.

296 expression on retinal neovascularization and leukocyte adhesion were abolished in mice lacking TNF-al

297 Similarly, leukocyte adhesions were significantly lower, with eleva

298 hyaluronan production or hyaluronan-mediated leukocyte adhesion when treated with the viral mimic pol

299 rolling phase resulting in the transition to leukocyte adhesion, which appear to contribute to chemok

300 tion of CatG specifically abrogated arterial leukocyte adhesion without affecting myeloid cell adhesi